CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years A prospective natural-history study of coronary atherosclerosis 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion The REVASC Trial Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association Routine Continuous Electrocardiographic Monitoring Following Percutaneous Coronary Interventions Microthrombi As A Major Cause of Cardiac Injury in COVID-19: A Pathologic Study Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes
|<<... 12 13 14 15 16 17 18 ...>>|

Clinical TrialVolume 13, Issue 9, May 2020

JOURNAL：JACC: Cardiovascular Interventions Article Link

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

RA Buiten, EH Ploumen, P Zocca et al. Keywords: zotarolimus-eluting stent; ZES; sirolimus-eluting stent; SES; TVF

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top